Literature DB >> 23893004

Solid organ transplants in HIV-infected patients.

Jack Harbell1, Norah A Terrault, Peter Stock.   

Abstract

There is a growing need for kidney and liver transplants in persons living with HIV. Fortunately, with the significant advances in antiretroviral therapy and management of opportunistic infections, HIV infection is no longer an absolute contraindication for solid organ transplantation. Data from several large prospective multi-center cohort studies have shown that solid organ transplantation in carefully selected HIV-infected individuals is safe. However, significant challenges have been identified including prevention of acute rejection, management of drug-drug interactions and treatment of recurrent viral hepatitis. This article reviews the selection criteria, outcomes, and special management considerations for HIV-infected patients undergoing liver or kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893004      PMCID: PMC5899895          DOI: 10.1007/s11904-013-0170-z

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  65 in total

1.  Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.

Authors:  J A Winston; L A Bruggeman; M D Ross; J Jacobson; L Ross; V D D'Agati; P E Klotman; M E Klotman
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

2.  Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.

Authors:  C S Coffin; P G Stock; L M Dove; C L Berg; N N Nissen; M P Curry; M Ragni; F G Regenstein; K E Sherman; M E Roland; N A Terrault
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

3.  HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients.

Authors:  Jianxin Qiu; Paul I Terasaki; Kayo Waki; Junchao Cai; David W Gjertson
Journal:  Transplantation       Date:  2006-06-27       Impact factor: 4.939

4.  Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients.

Authors:  Jack Harbell; John Fung; Nicholas Nissen; Kim Olthoff; Sander S Florman; Douglas W Hanto; Jimmy Light; Steve T Bartlett; Andreas G Tzakis; Thomas C Pearson; Burc Barin; Michelle E Roland; Peter G Stock
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

5.  Prevalence and risk factors for anal squamous intraepithelial lesions in women.

Authors:  E A Holly; M L Ralston; T M Darragh; R M Greenblatt; N Jay; J M Palefsky
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

6.  Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.

Authors:  Mysore S Anil Kumar; Debra R Sierka; Anna M Damask; Billie Fyfe; Robert F McAlack; Michael Heifets; Michael J Moritz; Daniel Alvarez; Aparna Kumar
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

7.  Renal transplantation between HIV-positive donors and recipients.

Authors:  Elmi Muller; Delawir Kahn; Marc Mendelson
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

Review 8.  Malignancy in the HIV-infected patients undergoing liver and kidney transplantation.

Authors:  Nicholas N Nissen; Burc Barin; Peter G Stock
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

9.  Spectrum of AIDS-associated malignant disorders.

Authors:  J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

10.  Survival of human immunodeficiency virus-infected liver transplant recipients.

Authors:  Margaret V Ragni; Steven H Belle; KyungAh Im; Guy Neff; Michelle Roland; Peter Stock; Nigel Heaton; Abhi Humar; John F Fung
Journal:  J Infect Dis       Date:  2003-11-12       Impact factor: 5.226

View more
  6 in total

1.  Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient.

Authors:  Dario Cattaneo; Salvatore Sollima; Nitin Charbe; Chiara Resnati; Emilio Clementi; Cristina Gervasoni
Journal:  Eur J Clin Pharmacol       Date:  2015-09-12       Impact factor: 2.953

2.  The Challenges and Promise of HIV-Infected Donors for Solid Organ Transplantation.

Authors:  Aaron Richterman; Emily Blumberg
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

3.  Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.

Authors:  Michelle E Roland; Burc Barin; Shirish Huprikar; Barbara Murphy; Douglas W Hanto; Emily Blumberg; Kim Olthoff; David Simon; William D Hardy; George Beatty; Peter G Stock
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

Review 4.  Kidney Transplantation in HIV-positive Patients: Current Practice and Management Strategies.

Authors:  Elmi Muller; Francois C J Botha; Zunaid A Barday; Kathryn Manning; Peter Chin-Hong; Peter Stock
Journal:  Transplantation       Date:  2021-07-01       Impact factor: 5.385

Review 5.  HIV and Solid Organ Transplantation: Where Are we Now.

Authors:  Jean Botha; June Fabian; Harriet Etheredge; Francesca Conradie; Caroline T Tiemessen
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

6.  Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States.

Authors:  Isabel Campos-Varela; Jennifer L Dodge; Marina Berenguer; René Adam; Didier Samuel; Fabrizio Di Benedetto; Vincent Karam; Luca S Belli; Christophe Duvoux; Norah A Terrault
Journal:  Transplantation       Date:  2020-10       Impact factor: 5.385

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.